Physician profile
Bryan J Hammer
NPI 1992766026
$417.88
in general payments reported to CMS, 2019-2025
10 companies · $82.29 in 2025
The $82.29 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.65 · 2020: $18.43 · 2021: $26.17 · 2022: $42.36 · 2023: $150 · 2024: $35.38 · 2025: $82.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $162.15 | 2022-2025 | Clareon, Centurion, Hydrus Microstent |
| Abbvie INC. | $46.83 | 2023 | |
| The Cameron-Ehlen Group, INC. | $46.74 | 2019-2020 | |
| Amgen INC. | $37.48 | 2025 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $28.10 | 2025 | Xdemvy |
| Horizon Therapeutics Plc | $26.17 | 2021 | |
| Allergan, INC. | $19.64 | 2019 | |
| Eyepoint US, INC. | $17.97 | 2023 | |
| Bausch & Lomb Americas INC. | $17.10 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $15.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Hammer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.